Replication-competent retroviruses in gene-modified T cells used in clinical trials: Is it time to revise the testing requirements?

Adham S. Bear, Richard A. Morgan, Kenneth Cornetta, Carl H. June, Gwendolyn Binder-Scholl, Mark E. Dudley, Steven A. Feldman, Steven A. Rosenberg, Sheila A. Shurtleff, Cliona M. Rooney, Helen E. Heslop, Gianpietro Dotti

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)246-249
Number of pages4
JournalMolecular Therapy
Volume20
Issue number2
DOIs
StatePublished - Feb 2012
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery

Cite this